Abstract
Over the last few years, samples from the marine environment have been screened for a variety of compounds with different biological activities. Among all marine organisms, sponges represent one of the most promising sources of leads in the research of new cancer drugs. However, there are few reports on screening Brazilian marine sponges for biological activities. In the following review, the current status of natural product research relating to Brazilian marine sponges is summarized, particularly for compounds demonstrating potential antitumor activity.
Keywords: Brazilian marine sponges, cancer, natural products, marine environment, cancer drugs, screening Brazilian, drug leads, sterols, Brazilian coastline, ovarian cancer cell line
Current Pharmaceutical Biotechnology
Title: Current Status on Natural Products with Antitumor Activity from Brazilian Marine Sponges
Volume: 13 Issue: 1
Author(s): Mario Luiz Conte da Frota Junior, Renata Biegelmeyer da Silva, Beatriz Mothes, Amelia Teresinha Henriques and Jose Claudio Fonseca Moreira
Affiliation:
Keywords: Brazilian marine sponges, cancer, natural products, marine environment, cancer drugs, screening Brazilian, drug leads, sterols, Brazilian coastline, ovarian cancer cell line
Abstract: Over the last few years, samples from the marine environment have been screened for a variety of compounds with different biological activities. Among all marine organisms, sponges represent one of the most promising sources of leads in the research of new cancer drugs. However, there are few reports on screening Brazilian marine sponges for biological activities. In the following review, the current status of natural product research relating to Brazilian marine sponges is summarized, particularly for compounds demonstrating potential antitumor activity.
Export Options
About this article
Cite this article as:
Luiz Conte da Frota Junior Mario, Biegelmeyer da Silva Renata, Mothes Beatriz, Teresinha Henriques Amelia and Claudio Fonseca Moreira Jose, Current Status on Natural Products with Antitumor Activity from Brazilian Marine Sponges, Current Pharmaceutical Biotechnology 2012; 13 (1) . https://dx.doi.org/10.2174/138920112798868674
DOI https://dx.doi.org/10.2174/138920112798868674 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiovascular Drug Development Using Radiopharmaceuticals
Current Pharmaceutical Design Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
Recent Patents on CNS Drug Discovery (Discontinued) Glycogen Metabolism and Brain Pathologies
Central Nervous System Agents in Medicinal Chemistry Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
Current Medicinal Chemistry Magnetic Field-Assisted Gene Delivery: Achievements and Therapeutic Potential
Current Gene Therapy Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies
Current Cancer Drug Targets Alkaloid-Metal Based Anticancer Agents
Current Topics in Medicinal Chemistry Disintegrins
Current Drug Targets - Cardiovascular & Hematological Disorders <i>In Vivo</i> Tracking of Novel SPIO-Molday ION Rhodamine-B™-Labeled Human Bone Marrow-Derived Mesenchymal Stem Cells After Lentivirus- Mediated COX-2 Silencing: A Preliminary Study
Current Gene Therapy Editorial (Thematic Selection: Mitochondrial Dysfunction & Neurological Disorders)
Current Neuropharmacology <i>In vivo</i> Anticancer Potential of Hydroxamic Acid Derivatives
Current Topics in Medicinal Chemistry Effect of DNA Repair Deficiencies on the Cytotoxicity of Drugs Used in Cancer Therapy - A Review
Current Medicinal Chemistry Prognostic and Predictive Biomarkers in Cancer
Current Cancer Drug Targets The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design Adhesion Molecules as Targets for the Treatment of Neoplastic Diseases
Current Pharmaceutical Design mTOR Inhibitors in Tuberous Sclerosis Complex
Current Neuropharmacology Proteomics Annotation of Lipid Rafts Modified by Virus Infection
Combinatorial Chemistry & High Throughput Screening Obesity and Inflammation: Colorectal Cancer Engines
Current Molecular Pharmacology Regulation of the Urokinase Receptor (uPAR) by LDL Receptor-related Protein-1 (LRP1)
Current Pharmaceutical Design Adenovirus-mediated Transgene-engineered Dendritic Cell Vaccine of Cancer
Current Gene Therapy